Skip to content The UAE's healthcare market is growing rapidly. Registering pharmaceutical products with the Emirates Drug Establishment (EDE) and MOHAP proves your medicines meet UAE standards for safety, effectiveness, and compliance building the trust and credibility essential for success in this competitive, lucrative market.
Excellent
5 Star Ratings
Pharmaceutical product registration is the mandatory approval process by the Emirates Drug Establishment (EDE) and Ministry of Health and Prevention (MOHAP) enabling legal sales in the UAE. It evaluates your product’s safety, quality, effectiveness, manufacturing standards, and international compliance, ensuring only safe, effective medicines reach patients.
The UAE is a strategic gateway to the GCC region, offering access to over 10 million residents and neighboring Gulf countries. Its world-class healthcare infrastructure, advanced medical facilities, and commitment to innovation make it an ideal hub for pharmaceutical companies targeting Middle East and North Africa markets.
The EDE and MOHAP maintain highly efficient pharmaceutical approval systems, with the UAE ranking first or second globally for innovative drug approval speed. This creates a competitive market where registered products gain immediate credibility. Major hospital networks, pharmacy chains, and healthcare providers require proper registration certificates, giving your brand instant trust with doctors, pharmacists, and patients.
Our Team of professional advisors will contact you for a tailored package that suits your requirements
Registration ensures products meet strict safety and quality standards through rigorous evaluation of manufacturing practices, ingredient quality, clinical effectiveness, and labeling, protecting patients from harm.
All pharmaceutical products require EDE registration before import, distribution, sale, or use in UAE. Non-compliance results in seizures, fines, penalties, and legal action.
Only registered products can legally enter UAE healthcare for prescription or sale. Registration provides official recognition, protects IP, and enables distribution across healthcare facilities.
EDE and MOHAP registration builds credibility with doctors, pharmacists, and healthcare institutions, confirming your products meet international standards for confident prescribing and dispensing.
We handle all documents required for EDE and MOHAP registration, ensuring full compliance.
We provide regulatory guidance and quality verification ensuring products meet UAE and international pharmaceutical standards.
Professional labeling services meeting EDE and MOHAP's strict bilingual requirements for all UAE pharmaceutical products.
Expert handling of EDE and MOHAP online systems for seamless digital application submission and tracking.
Pharmaceutical products registered and market-ready in as little as 45 working days
Standard registration: 45 days
Fast-track innovative/orphan drugs: 25 days
Comprehensive product review and compliance evaluation. We analyze your formulation, assess EDE and MOHAP requirements, identify the registration pathway, and create a customized strategy.
Complete eCTD dossier compilation including clinical data, stability studies, GMP certificates, CPP documentation, and Arabic translations, meeting EDE and MOHAP standards with attestation.
Professional EDE portal submission via UAE PASS with all attachments, fee processing (AED 100 plus product fees), confirmation, and tracking reference number.
EDE evaluation with active monitoring, query response, and additional documentation submission if needed. Technical committee reviews product safety, efficacy, and quality standards.
Laboratory analysis coordination if needed, including bioequivalence studies, stability testing, pharmacovigilance plan evaluation, and product sample analysis at approved facilities.
Final approval confirmation, 5-year registration certificate issuance, product pricing approval (48 hours to 90 days), and official UAE and GCC market authorization.
98% first-time success through precise eCTD documentation and deep EDE and MOHAP expertise.
Complete end-to-end service: assessment, dossier preparation, submission, translations, attestation, and certificate delivery.
Dedicated regulatory specialists provide real-time updates and guide you through every registration step.
Trusted by international pharmaceutical companies and local distributors with proven complex registration expertise.
Clear timelines, upfront fees, no hidden costs, smooth process from consultation to authorization.
Specialized expertise in EDE regulations, MOHAP compliance, fast-track pathways, and GCC reliance procedures.
The UAE pharmaceutical market is experiencing rapid growth, with healthcare spending projected to reach $20 billion by 2026. Whether you’re a multinational pharmaceutical company or a regional distributor, proper registration with the Emirates Drug Establishment (EDE) is your gateway to one of the fastest-growing healthcare markets in the world.
Pharmaceutical product registration is the official approval process conducted by the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP). It is legally required before any medicine can be imported, distributed, sold, or used in the UAE. Without registration, products are subject to seizures, fines, and legal action.
Standard registration takes approximately 45 working days. Fast-track approval for innovative or orphan drugs can be completed in as little as 25 days. Timelines depend on documentation completeness, the product category, and whether additional laboratory testing is required.
You need a valid UAE trade license with pharmaceutical activity, a complete eCTD product dossier (Modules 1–5), a Certificate of Pharmaceutical Product (CPP) from the country of origin, GMP certificates with UAE Embassy attestation, and bilingual Arabic/English product labels. A licensed warehouse facility and an authorized Marketing Authorization Holder (MAH) agreement are also required.
The EDE portal application fee starts at AED 100 plus applicable product fees. Additional costs include dossier preparation, Arabic translation, attestation, and any required laboratory testing. For a precise cost breakdown, a consultation is recommended as fees vary by product type and registration pathway.
Only UAE-licensed entities whether mainland or freezone companies in pharmaceuticals, healthcare, or trading can submit applications. Foreign manufacturers must appoint a local authorized agent, distributor, or Marketing Authorization Holder (MAH) to handle registration and ongoing compliance on their behalf.
The process involves six stages: initial product assessment, eCTD dossier preparation, EDE portal submission via UAE PASS, authority review and query response, laboratory testing if required, and final certificate issuance. The entire process typically takes 45 working days, with the certificate valid for five years.
The eCTD (Electronic Common Technical Document) is the globally standardized format for submitting pharmaceutical dossiers. The EDE requires all applications to follow this structure across five modules covering administrative data, quality, non-clinical, and clinical information. Non-compliant submissions are typically rejected at the screening stage.
Yes. The UAE participates in the GCC reliance pathway, which streamlines approvals across Gulf Cooperation Council countries. A UAE registration can significantly accelerate market access in neighboring Gulf markets, making UAE a strategic regional entry point.
The EDE offers an expedited 25-day approval pathway for innovative medicines and orphan drugs. This pathway is designed for products addressing unmet medical needs. It requires the same documentation standards but is reviewed under an accelerated technical committee process.
The EDE registers a wide range of products, including conventional tablets and injectables, biological and biosimilar products, OTC medicines, herbal and natural formulations, controlled and narcotic substances, and medical devices and diagnostics. Each category has specific documentation and compliance requirements.
All pharmaceutical products must carry bilingual labels in both Arabic and English. Labels must include a full ingredient list using international nomenclature, dosage and usage instructions in Arabic, manufacturing and expiry dates, and storage conditions. Patient information leaflets must also be provided in Arabic.
A Marketing Authorization Holder is the legally responsible entity that holds the product registration certificate and is accountable for the product’s safety, quality, and compliance in the UAE market. Foreign companies without a UAE presence must appoint a licensed local MAH or authorized agent before registration can proceed.
Foreign companies cannot apply directly without UAE representation. They must appoint a locally licensed authorized agent, distributor, or MAH with a valid UAE trade license. This local entity acts as the regulatory point of contact with EDE and MOHAP throughout the product’s lifecycle.
Upon approval, a five-year registration certificate is issued. Product pricing approval follows, which typically takes between 48 hours and 90 days depending on the product. The registration must be renewed before expiry, and any changes to the product require a variations approval submission to remain compliant.
MOHAP (Ministry of Health and Prevention) works alongside the EDE to regulate pharmaceutical products in the UAE. Together they evaluate product safety, efficacy, quality, and manufacturing standards. MOHAP guidelines govern labeling, pricing, distribution channels, pharmacovigilance requirements, and GCC regulatory cooperation.
We’re here to help. If you didn’t find the answer you were looking for, feel free to reach out to our team. We’ll make sure you get the clarity you need to move forward with confidence.
Don't let regulatory complexity delay market entry. Our pharmaceutical registration experts fast-track your products to UAE healthcare with full compliance, transparency, and professional support throughout the process.
Optimized by Seraphinite Accelerator